Collegium Pharmaceutical Inc stock is traded at $25.16, with a volume of 1,574,719. It is up +6.29% in the last 24 hours and up +15.04% over the past month. Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
Previous Close:
$23.67
Open:
$25.74
24h Volume:
1,574,719
Relative Volume:
2.37
Market Cap:
$819.10M
Revenue:
$796.33M
Net Income/Loss:
$74.95M
P/E Ratio:
12.32
EPS:
$2.04
Net Cash Flow:
$329.83M
1W Performance:
+4.70%
1M Performance:
+15.04%
6M Performance:
-28.77%
1Y Performance:
-29.82%
1-Day Range:
$24.32$26.39
1-Week Range:
$23.25$26.39
52-Week Range:
$21.43$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Name
Collegium Pharmaceutical IncSector
HealthcarePhone
781-713-3699Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS